Newcastle Disease Virus Antikörper
-
- Target Alle Newcastle Disease Virus (NDV) Produkte
- Newcastle Disease Virus (NDV)
-
Reaktivität
- Newcastle Disease Virus (NDV)
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser Newcastle Disease Virus Antikörper ist unkonjugiert
-
Applikation
- ELISA
- Produktmerkmale
- Purified IgG
- Aufreinigung
- Purified
- Immunogen
- Glycoprotein haemagglutinin-neuraminidase of Newcastle Disease Virus (La-Sota strain)
- Klon
- 8H2
- Isotyp
- IgG2a
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1.0 mg/mL
-
-
Phase 1 clinical experience using intravenous administration of PV701, an oncolytic Newcastle disease virus." in: Current cancer drug targets, Vol. 7, Issue 2, pp. 157-67, (2007) (PubMed).
: "
-
Phase 1 clinical experience using intravenous administration of PV701, an oncolytic Newcastle disease virus." in: Current cancer drug targets, Vol. 7, Issue 2, pp. 157-67, (2007) (PubMed).
-
- Target
- Newcastle Disease Virus (NDV)
- Andere Bezeichnung
- NEWCASTLE DISEASE VIRUS (NDV Produkte)
- Substanzklasse
- Virus
- Hintergrund
- Synonyms: NDV
-